Skip to content
DataLookout
Start free
Menu

NCT07787689

Intermittent vs Alternate Daily Regimen of Prednisolone in Ambulatory Boys With Duchenne Muscular Dystrophy

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Treatment efficacy
Timeframe: 6 month after start of treatment

Secondary (2)

Weight gain
Hyperglycemia

Arms and interventions

Alternate-Day Prednisolone-GroupExperimental

Patients will be given alternate-day administration of prednisolone at a dose of 0.75 mg/kg/day.

Intermittent Prednisolone-GroupExperimental

Patients will be administered prednisolone at a dose of 0.75 mg/kg/day for 10 consecutive days, followed by a 10-day steroid-free period.

Drugs: Alternate-day prednisolone, Intermittent prednisolone

Sites

1 site in 1 country

  • Children's Hospital/University of Child Health SciencesLahore, Punjab Province, Pakistan